What it is

Copper-binding tripeptide studied in matrix, skin, and wound-repair literature.

Also known as

Copper peptide · GHK copper tripeptide · Glycyl-L-histidyl-L-lysine copper

Overview

GHK-Cu is a copper-binding tripeptide studied in extracellular-matrix, skin, and wound-repair literature. Research covers collagen and glycosaminoglycan-related markers, antioxidant signaling, and remodeling endpoints in dermal and injury models.

It appears both as a standalone research peptide and as a component of named regenerative blends. Left Turn Adventures supplies this compound for laboratory and research use only.

Proven benefits

Note: Preclinical / literature endpoints for labs — not established human treatment benefits. Not a protocol.

• Collagen and matrix-remodeling endpoints in skin models

• • Wound-repair and re-epithelialization markers

• • Antioxidant and anti-inflammatory readouts in dermal research

• • Hair-follicle and scalp-adjacent markers where studied

• • Gene-expression shifts linked to tissue remodeling in preclinical work

Results timeline

Note: Illustrative research-observation windows — not a clinical schedule. No dosing.

Week 1–2: Early tissue and inflammation readouts in acute injury or repair models; compound exposure establishing.

Week 3–4: Clearer repair, angiogenesis, and mobility-adjacent markers in short research windows.

Month 2–3: More pronounced tendon/ligament/soft-tissue endpoints in extended preclinical designs.

Month 3–6: Sustained remodeling and recovery-marker observations where studied longer.

The catalog, not a clinic

For laboratory and research use only. Not for human or animal consumption. Products are sold solely to qualified researchers and licensed laboratories. No dosing or reconstitution on this page.